THE DEAL, AT A GLANCE
From the announcementEnveda
01Who is involvedBacked by Catalio Capital Management</strong>, bringing its, Iconiq, natural chemistryFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedEnveda raised $311M Series E, announced 2026-09-23From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersEnveda’s $311 million Series E supports a platform thesis that AI-discovered natural medicines can produce clinic-ready and later-stage drug programs, with Catalio…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Enveda · Financing Record
Explore source-linked visual explanations for Enveda. Unsupported claims are withheld while source review continues.
Record 12671 · Recorded date: 2026-09-23
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →